Pulmonary hypertension in chronic liver disease

被引:119
作者
Mandell, MS
Groves, BM
机构
[1] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR,CARDIAC CATHETERIZAT LABS,DENVER,CO 80262
关键词
D O I
10.1016/S0272-5231(05)70296-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pulmonary hypertension develops in approximately 2% of patients with portal hypertension. Diagnosis is often difficult and requires a high degree of clinical suspicion. Treatment of patients with portal and pulmonary hypertension is limited, and mean survival following diagnosis is approximately 15 months. The effect of liver transplantation on the natural history of disease is discussed.
引用
收藏
页码:17 / &
页数:18
相关论文
共 137 条
[61]  
LANGLEBEN D, 1994, CHEST, V105, P13
[62]  
LEBREC D, 1979, AM REV RESPIR DIS, V120, P849
[63]   ELEVATION OF PLASMA ENDOTHELIN ASSOCIATED WITH SYSTEMIC HYPERTENSION IN HUMANS FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION [J].
LERMAN, A ;
CLICK, RL ;
NARR, BJ ;
WIESNER, RH ;
KROM, RAF ;
TEXTOR, SC ;
BURNETT, JC .
TRANSPLANTATION, 1991, 51 (03) :646-650
[64]  
LEVINE OR, 1973, J PEDIATR-US, V83, P964
[65]  
LOCKHART A, 1985, CLIN GASTROENTEROL, V14, P123
[66]  
LOUIE EK, 1986, J AM COLL CARDIOL, V8, P13077
[67]   PROGRESSIVE PLEXOGENIC PULMONARY-HYPERTENSION FOLLOWING LIVER-TRANSPLANTATION [J].
MANDELL, MS ;
GROVES, BM ;
DUKE, J .
TRANSPLANTATION, 1995, 59 (10) :1488-1490
[68]   NITRIC-OXIDE REDUCES PULMONARY-HYPERTENSION DURING HEPATIC TRANSPLANTATION [J].
MANDELL, MS ;
DUKE, J .
ANESTHESIOLOGY, 1994, 81 (06) :1538-1542
[69]  
MANTZ FA, 1951, AMA ARCH PATHOL, V52, P91
[70]   COMPARISON OF DOPPLER-DETERMINED ELEVATED PULMONARY ARTERIAL-PRESSURE WITH PRESSURE MEASURED AT CARDIAC-CATHETERIZATION [J].
MARTINDURAN, R ;
LARMAN, M ;
TRUGEDA, A ;
DEPRADA, JAV ;
RUANO, J ;
TORRES, A ;
FIGUEROA, A ;
PAJARON, A ;
NISTAL, F .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (10) :859-863